Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and pathological analysis of pulmonary epithelioid vascular endothelial tumor. | Open Life Sci | 2026 | 41726558 | PubTator, text mining | PubMed |
| Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss. | Sci Adv | 2026 | 41719400 | PubTator, text mining | PubMed |
| TFEB confers resistance against the chemotherapeutic agent CX-5461. | Autophagy Rep | 2026 | 41717449 | PubTator, text mining | PubMed |
| TFE3 fusion proteins drive TFE3 rearranged renal cell carcinoma progression via PGC-1α-mediated fatty acid oxidation. | Front Immunol | 2026 | 41716419 | PubTator, text mining | PubMed |
| Jatropadanes A-Q, lathyrane diterpenoids with lysosomal biogenesis potential from Jatropha podagrica Hook. | Phytochemistry | 2026 | 41687908 | PubTator, text mining | PubMed |
| Mammalian lipophagy: process and function. | Autophagy | 2026 | 41681129 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular features of acquired cystic disease-associated renal cell carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41644424 | PubTator, text mining | PubMed |
| Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma. | J Clin Invest | 2026 | 41623182 | PubTator, text mining | PubMed |
| Next-generation liquid biopsies: detecting circulating epigenetic changes to identify translocation renal cell carcinoma. | J Clin Invest | 2026 | 41623175 | PubTator, text mining | PubMed |
| Nutrition and longevity - diet in centenarians. | J Transl Med | 2026 | 41618331 | PubTator, text mining | PubMed |
| Emerging Role of ctDNA Fragmentomics and Epigenetic Signatures in the Early Detection, Minimal Residual Disease Assessment, and Precision Monitoring of Renal Cell Carcinoma. | J Cell Mol Med | 2026 | 41614220 | PubTator, text mining | PubMed |
| Advances in Renal Cell Carcinoma Diagnosis: A Review on Biomarkers. | Pathobiology | 2026 | 41591977 | PubTator, text mining | PubMed |
| Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience. | Ann Med | 2026 | 41578672 | PubTator, text mining | PubMed |
| Alternative Lengthening of Telomeres in Malignant Perivascular Epithelioid Cell Neoplasms: Correlation With Molecular Features Including ATRX Gene Mutation Status. | Mod Pathol | 2026 | 41577032 | PubTator, text mining | PubMed |
| TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists. | Adv Anat Pathol | 2026 | 41574499 | PubTator, text mining | PubMed |
| Hyperactivation of mTORC1 blocks stem cell fate transitions through TFE3-NuRD association. | EMBO Rep | 2026 | 41559473 | PubTator, text mining | PubMed |
| Renal cell carcinoma with anomalous vascular anatomy in a 15-year-old male: Case report with review of literature. | Urol Case Rep | 2026 | 41552401 | PubTator, text mining | PubMed |
| Renal cell carcinoma with biphasic morphology: A cohort showing similar morphology but distinct clinicopathological and molecular features. | Pathol Res Pract | 2026 | 41546988 | PubTator, text mining | PubMed |
| Rectal PEComa Mimicking Gastrointestinal Stromal Tumor on Endoscopic Ultrasound. | ACG Case Rep J | 2026 | 41537021 | PubTator, text mining | PubMed |
| A comprehensive review of ossifying fibromyxoid tumor: insights into its clinical, pathological, and molecular landscape. | J Pathol Transl Med | 2026 | 41531320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=6